Dolby Laboratories (DLB) Fair Value 2026

DLB · Patent Owners & Lessors ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.9 /10

32 fundamental signals · 13 models active

Value Trap Risk

LOW (25/100)

Quick Summary — As of 2026-07-13, Dolby Laboratories (DLB) trades at $49.34, approximately 32% below CirclFi’s Bayesian DCF fair value of $72.25. QOC: 8.9/10. Value Trap Risk: 25/100 (LOW). 13/13 models active.

Key Facts

Ticker
DLB
Price
$49.34
Quality Score
8.9/10
Value Trap Risk
25/100
Models Active
13/13
Last Updated
Strength: Bayesian DCF suggests +46.4% upside with 69% confidence
Risk: Majority of models suggest overvaluation

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($49.34)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$72.25 +46.4%
Earnings Power Value
High Conviction
$38.08 -22.8%
CUCE Ensemble
Medium Conviction
$40.50 -17.9%
First Chicago
High Conviction
$39.34 -20.3%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is Dolby Laboratories (DLB) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Dolby Laboratories's intrinsic value is estimated at a composite fair value of $40.56. Trading at $49.34, the stock is approaching fair value or slight overvaluation (implied return of -17.8%), as 9 of 13 models suggest limited further upside. The most optimistic model, Bayesian DCF, places fair value at $72.25 (+46.4%), while Dynamic NAV — the most conservative — estimates $16.44 (-66.7%). This +113.1% gap reflects genuine analytical uncertainty about Dolby Laboratories's intrinsic worth. Among models with highest confidence, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About DLB?

13 of 13 models are currently active for DLB. Of these, 3 models suggest upside while 10 models suggest overvaluation. The Bayesian DCF estimates DLB's intrinsic value at $72.25, implying +46.4% upside from the current price. See which stocks rank higher →

How Does DLB Rank in Patent Owners & Lessors?

Among 8 Patent Owners & Lessors stocks, DLB ranks #2 by Quality of Company score. CirclFi's QOC score of 8.9/10 evaluates 32 fundamental signals. A score of 8.9 places DLB in the top tier.

Dolby Laboratories operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is DLB a Value Trap?

CirclFi's Value Trap algorithm assigns DLB a score of 25/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for Dolby Laboratories. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Dolby Laboratories scores 8.9 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +113.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every DLB valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across DLB's 13 active models, average confidence is 53%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Dolby Laboratories Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Patent Owners & Lessors Stocks Should You Also Analyze?

7 related Patent Owners & Lessors stocks with 13-model coverage

Read investment analysis: IDCC · JYNT · REFR · NTIP · VHC

Frequently Asked Questions About Dolby Laboratories

What is Dolby Laboratories's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Dolby Laboratories (DLB) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $72.25. The Quality of Company score is 8.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is DLB overvalued or undervalued right now?

At $49.34, 3 of 13 active models suggest DLB may be undervalued, while 10 indicate potential overvaluation. The assessment depends on which methodology best fits Dolby Laboratories's business model in Patent Owners & Lessors.

What does a Quality of Company score of 8.9 mean for DLB?

Dolby Laboratories's QOC of 8.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on DLB?

CirclFi analyzes DLB with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is DLB a value trap in 2026?

Dolby Laboratories's Value Trap score is 25/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on DLB.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access